Tag:
Prezista
Latest Headlines
Latest Headlines
Gilead Sciences, J&J up the ante on new HIV drug combos
Gilead Sciences ( $GILD ) and Johnson & Johnson ( J&J ) are taking their close partnership on new HIV drug combos to the proverbial next level. About four months since their deal to mix Gilead's
Gilead inks one combo HIV drug pact as it explores new ties with J&J
HIV powerhouse Gilead and Johnson & Johnson's Tibotec subsidiary are joining forces on a combo HIV treatment. Under a new pact Gilead will combine its new boosting agent cobicistat with J&J's
Stink strikes J&J again, prompting Prezista recall
That old musty smell has prompted another recall at Johnson & Johnson. This time, it's the HIV fighter Prezista. The company's Janssen unit will pull at least 11,700 bottles of the drug in Europe
J&J gets nod for broader use of HIV med
Johnson & Johnson scored a big expansion in use for its HIV drug Prezista. The FDA gave the nod for the drug to be used to treat patients who've never used any other anti-HIV meds. Prezista,
